Cambridge, UK, August 4th 2014 — Evolva Holding SA (SIX: EVE) has today announced the acquisition of Prosarix Ltd.
Evolva and Prosarix have worked extensively together on multiple projects and products for eight years, in a progressively more integrated manner. This ever-deepening collaboration led both companies to conclude that a full combination and alignment of interests was the next logical step in furthering the relationship.
Prosarix’s capabilities will be integrated into all Evolva current and future projects and partnerships. Examples of areas where Prosarix’s technologies complement Evolva’s include:
Commitments to Prosarix’s existing customers and partners will be fulfilled. Prosarix’s operations near Cambridge UK will be maintained and Prosarix employees will become Evolva employees.
About Evolva
Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, vanilla, saffron and resveratrol. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com.
For Evolva's Press release, please see Evolva Press Release.
©Prosarix 2007-2020
℅ RxCelerate Ltd, Moneta B280, Babraham Research Park, Cambridge, CB22 3AT ¦ +44 (0)1223 839557 ¦ contact@prosarix.com ¦ legal